Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Status:
Terminated

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Tumor Imaging of I-124 PGN65 in Solid Tumors

Early Phase 1

Peregrine Pharmaceuticals